NEW YORK - TG Therapeutics, Inc. (NASDAQ: TGTX), a biopharmaceutical company with a market capitalization of $5.4 billion and impressive revenue growth of 41% in the last twelve months, today shared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback